MammoSite Brachytherapy Catheter Faces Reimbursement Difficulties

Temporary codes denoting Proxima Therapeutics' MammoSite high-dose rate brachytherapy catheter are necessary to allow sufficient reimbursement of the technology under the hospital OPPS, according to the Pinnacle Health Group (PHG)

More from Archive

More from Medtech Insight